+ Bookmark This Page    
Preferences  |  3:51 AM
  1. Home
  2. Latest Press Releases
  3. Submit Press Releases
  1. PR Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
   
Filter News
Show All Results

Show Filtered Results

Category
- Internet (x)

Country
- South Africa (x)

State / Province
(To see all states,
remove category filter)


City / Town
Select State First

NAPRX® adds several new compliance officers to aid clients/customers to comply with PhRMA Code.

PhRMA revises its code of conduct to ensure their medicines are marketed in a manner that benefits patients and the enhances the practices of medicine. NAPRX® adds several new compliance officers to aid in the process to comply with the new code.
 

FOR IMMEDIATE RELEASE

PRLog (Press Release)Nov 06, 2008 – In a major revision to its code of conduct, the Pharmaceutical Research and Manufacturers of America has revised its PhRMA code, banning the distribution of non-educational branded leave behinds. "This updated code fortifies the our companies' commitment to ensure their medicines are marketed in a manner that benefits patients and enhances the practice of medicine," explained Billy Tauzine, president and CEO of PhRMA in a statement announcing the changes.

The new code promises to have immediate on pharmaceutical sales reps. One of the biggest changes is the prohibition of handing out non-educational items like pens, pads, and mugs with a company or drug logo. Although such items tend to have minimal value, PhRMA notes that gifts “may foster misperceptions that company interactions with healthcare professionals are not based on informing them about medical and scientific issues.” The revised code also discourages pharmaceutical sales representatives from offering meals in restaurants to physicians and other healthcare professionals. Meals provided in the physician’s office when combined with informational information are still permissible. The new guidelines strengthen earlier admonitions that pharmaceutical companies should not provide entertainment or recreational benefits.

Another new provision will directly impact pharmaceutical sales rep training. Representative should be sufficiently trained about laws, regulations and industry codes of practice that govern interactions with healthcare professionals, according to the revised code. PhRMA suggests that companies assess reps periodically about the new standards of conduct and take actions against reps who do not meet the guidelines.

Qualified or aspiring pharmaceuitcal sales applicants should be familiar with clinical pharmacology, medical terminology, plus rules and regulations for selling pharmaceuticals to effectively sell to healthcare professionals. Applicants who have no previous pharmaceutical sales experience but who have acquired industry sales training, pharmaceutical product knowledge, managed care guidelines plus selling regulations will always be more qualified versus others without it. No successful pharmaceutical sales professional will be successful unless they have to up-to-date pharmaceutical industry education and product knowledge.  The NAPRX® provides vocational pharmaceutical sales education (CNPR® Training) that candidates add to their resume to attract pharmaceutical employers.

PhRMA is also asking pharmaceutical company CEO's and compliance officers to certify each year that they have proceses in place to comply with the code of conduct. PhRMA even suggests that companies should look to hire outside firms to verify that they have processes in place.

# # #

The largest association in the United States representing over 48,000 pharmaceutical sales representatives.


To embed this press release, copy and paste the following HTML code into your webpage-
# # # Click to see PDF Version of this Press Release

Email to a Friend     Visit Press Room       Previous News   Next News


Issued By:NAPRX®
Email Contact:Click to email
Phone:800 913-0701
Address:2020 Pennsylvania Avenue # 5050
City/Town:Washington
State/Province:District of Columbia
Zip:20006
Country:United States
Categories:Health, Biotech, Education
Tags:naprx, naprx, national association of pharmaceutical representatives, cnpr, naprx manual
Last Updated:Nov 06, 2008
Shortcut:http://prlog.org/10137759

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Latest Press Releases From “NAPSRX”


Upcoming Press Releases...


Related?

NAPRx Forecasts 4.5 - 5.5 Percent Growth for Pharmaceutical Market in 2009, Exceeding $820 Billion

Novo Nordisk Signs Recruitment Advertising Agreement with the NAPRx® for Pharmaceutical Sales Jobs

The NAPRx® Announces its Agreement as An Official Media Partner with PharmaForce 2008

U.S. Department of Labor Recognizes The NAPRx® - CNPR® Training for Pharmaceutical Sales Career

Pharmaceutical Industry Looks To Grow In 2009 -- Sales Opportunities Exist With Many Companies


Most Viewed Weekly

Responding to H1N1 Flu-like Symptoms and H1N1 Flu Prevention - 6839 views

Movie about Sirius XM Radio Gets Worldwide Distribution Deal - 2454 views

Sprint Nextel Corporation faces long term shareholder investigation - 1779 views

Service Records Of Two Million First World War British Soldiers Now Online - 1274 views

Apollo Group, Inc. faces shareholder investigation - 1265 views


Daily News!

Diabetes Congress opens in Dubai

Proud to be BITSian Ranvir Trehan visits alma mater BITS Pilani

Gladys Magazine Announces our First Model Search!

Chile prepares pitch for free trade with GCC

5i Conseil now providing training on integrated system with ROTOCONTROL, AVT and Domino

Previous   Next

Nov 06, 2008 News

Nov 2008 News

Are you a Journalist?

For Businesses ...

Tutorial on Free Marketing


November 2009
Mo Su Sa Fr Th We Tu
9 8 7 6 5 4 3
2 1
October 2009
31 30 29 28 27
26 25 24 23 22 21 20
19 18 17 16 15 14 13



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice